Tau PET/CT Imaging in the Mismatch Prospective Cohort Study (MPC-TAU)

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Drug
Study Type: Observational
SUMMARY

To collect Tau PET/CT imaging in older adults diagnosed with Mild Cognitive Impairment (MCI) or Alzheimer's Disease (AD) in the Mismatch Prospective Cohort Study (MPC-Tau) study to determine relationship to clinical, cognitive, and other biomarker data. Findings from this study will likely provide insight into the phenotypic variability of Alzheimer's Disease and other related pathologies.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 120
Healthy Volunteers: f
View:

• Enrolled in MPC study (Protocol 850160 at UPenn; Protocol 2022P002447 at MGH).

• Reliable study partner to accompany participant to the PET/CT scan

• A brain MRI must be performed within 6 months prior to their study AV-1451 TAU PET/CT scan date and be deemed of adequate quality that the scan may be used for study analysis, including 3T high-resolution imaging of medial temporal lobe structures.

Locations
United States
Massachusetts
Massachusetts General Hospital
RECRUITING
Boston
Pennsylvania
University of Pennsylvania
RECRUITING
Philadelphia
Contact Information
Primary
Jacqueline Lane
Jacqueline.Lane@pennmedicine.upenn.edu
610-299-1243
Time Frame
Start Date: 2023-03-14
Estimated Completion Date: 2029-12
Participants
Target number of participants: 100
Related Therapeutic Areas
Sponsors
Leads: University of Pennsylvania
Collaborators: Massachusetts General Hospital

This content was sourced from clinicaltrials.gov